Integrated serum metabolomics reveals severity-associated exploratory metabolic signatures in burn patients
Frontiers in Physiology · 17.06.2026 · 17
DOI: 10.3389/fphys.2026.1846440 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Physiology, online erschienen am 17.06.2026. Verfasst von Zhenyu Cheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Zhengzhou First People's Hospital, Zhengzhou, China. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To systematically characterize the serum metabolome of burn patients using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Patients were stratified by burn severity based on total body surface area (TBSA; ≥30% vs. <30%). Exploratory metabolic signatures and candidate biomarkers associated with burn severity were investigated.
Methods
Peripheral serum samples were collected from patients with TBSA ≥30% (n=33), TBSA <30% (n=28), and healthy controls (n=18). Serum metabolomic profiling was performed by UPLC-MS/MS. Principal component analysis (PCA) and orthogonal partial least squares-discriminant analysis (OPLS-DA) were applied to identify differential metabolites. Pathway enrichment analysis was conducted using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database via MetaboAnalyst. Receiver operating characteristic curve (ROC) analysis was performed to preliminarily evaluate the discriminatory performance of exploratory candidate biomarkers.
Results
Distinct metabolic dysregulation was observed between burn severity groups. Compared with the healthy control group, twenty-three significantly altered metabolites were identified in patients with TBSA ≥30%, while thirty-one metabolites were altered in patients with TBSA <30%. Severe burns (TBSA ≥30%) predominantly disrupted amino acid and glycerophospholipid metabolism, whereas moderate burns (<30%) mainly involved lipid-related pathways. Patients with TBSA ≥30% exhibited perturbations across a broader range of metabolic pathways. ROC analysis identified nine exploratory candidate biomarkers (area under the curve [AUC] >0.8) in patients with TBSA ≥30% and eight in patients with TBSA <30%, suggesting preliminary discriminatory potential within the current cohort for distinguishing metabolic alterations associated with different burn severities.
Conclusion
Burn severity may be associated with distinct serum metabolomic signatures. Key pathways and exploratory candidate biomarkers associated with burn severity-related metabolic alterations were identified. These findings provide a metabolomics-based reference framework for future studies investigating burn severity-associated metabolic alterations and may support future mechanistic and translational research in burn care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Zhengzhou First People's Hospital, Zhengzhou, China.
- Henan University of Chinese Medicine, Zhengzhou, China.
Zitieren
APA
Cheng, Z., Li, K., Ran, S., Zhang, L., Li, X., Han, D., Wang, S., He, L., Xu, M., Li, M., Huang, H., & Di, H. (2026). Integrated serum metabolomics reveals severity-associated exploratory metabolic signatures in burn patients. Frontiers in Physiology, 17. https://doi.org/10.3389/fphys.2026.1846440
Vancouver
Cheng Z, Li K, Ran S, Zhang L, Li X, Han D, et al. Integrated serum metabolomics reveals severity-associated exploratory metabolic signatures in burn patients. Frontiers in Physiology. 2026;17. doi:10.3389/fphys.2026.1846440
BibTeX
@article{Cheng2026,
author = {Cheng, Zhenyu and Li, Kang and Ran, Shaoyun and Zhang, Liming and Li, Xiaoliang and Han, Dawei and Wang, Shuai and He, Leifeng and Xu, Mengdan and Li, Meng and Huang, Haiying and Di, Haiping},
title = {Integrated serum metabolomics reveals severity-associated exploratory metabolic signatures in burn patients},
journal = {Frontiers in Physiology},
year = {2026},
volume = {17},
doi = {10.3389/fphys.2026.1846440}
}
EUVIMED